Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan
Crossref DOI link: https://doi.org/10.1007/s11060-017-2385-0
Published Online: 2017-03-06
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Farina, Patrizia
Tabouret, Emeline
Lehmann, Pierre
Barrie, Maryline
Petrirena, Gregorio
Campello, Chantal
Boucard, Celine
Graillon, Thomas
Girard, Nadine
Chinot, Olivier
Funding for this research was provided by:
siric (INCa-DGOS-Inserm 6038)
License valid from 2017-03-06